Psoriasis and metabolic disease: Epidemiology and pathophysiology

Rahat S. Azfar, Joel M. Gelfand

Research output: Contribution to journalReview articlepeer-review

220 Scopus citations

Abstract

The broad literature linking psoriasis to metabolic disorders has led to changes in standard of care recommendations for patients with psoriasis. In particular, practitioners are encouraged to screen psoriasis patients, especially when disease is severe, for metabolic disorders and cardiovascular risk factors and institute appropriate prevention strategies. Additional studies investigating the role of psoriasis activity and severity as an independent risk factor for developing metabolic disorders, atherosclerosis, and myocardial infarction and the role of psoriasis treatment in altering the risk of developing these serious morbidities are urgently needed.

Original languageEnglish
Pages (from-to)416-422
Number of pages7
JournalCurrent Opinion in Rheumatology
Volume20
Issue number4
DOIs
StatePublished - Jul 2008
Externally publishedYes

Keywords

  • Epidemiology
  • Inflammation
  • Metabolic syndrome
  • Myocardial infarction
  • Psoriasis

Fingerprint

Dive into the research topics of 'Psoriasis and metabolic disease: Epidemiology and pathophysiology'. Together they form a unique fingerprint.

Cite this